<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Valdecoxib</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00580</strong>&#160; (APRD00183, DB07576)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>investigational, withdrawn</td></tr><tr><th>Description</th><td><p>Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00580/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00580/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00580.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00580.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00580.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00580.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00580.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00580">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Bextra</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-inflammatory-agents-non-steroidal">Anti-Inflammatory Agents, Non-Steroidal</a></li></ul></td></tr><tr><th>CAS number</th><td>181695-72-7</td></tr><tr><th>Weight</th><td>Average: 314.359<br>Monoisotopic: 314.072513014</td></tr><tr><th>Chemical Formula</th><td>C<sub>16</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>S</td></tr><tr><th>InChI Key</th><td>LNPDTQAFDNKSHK-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Phenylpropanoids and Polyketides</td></tr><tr><th>Class</th><td>Stilbenes</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Stilbenes</td></tr><tr><th>Alternative parents</th><td>Benzenesulfonamides; Sulfonyls; Sulfonamides; Isoxazoles; Polyamines</td></tr><tr><th>Substituents</th><td>benzenesulfonamide; benzene; sulfonic acid derivative; sulfonyl; azole; isoxazole; sulfonamide; polyamine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups  to a phenyl ring lead to stilbenoids.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of osteoarthritis and dysmenorrhoea</td></tr><tr><th>Pharmacodynamics</th><td>Valdecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug (NSAID). Valdecoxib is used for its anti-inflammatory, analgesic, and antipyretic activities in the management of osteoarthritis (OA) and for the treatment of dysmenorrhea or acute pain. Unlike celecoxib, valdecoxib lacks a sulfonamide chain and does not require CYP450 enzymes for metabolism.</td></tr><tr><th>Mechanism of action</th><td>Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane. Valdecoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, important for the mediation of inflammation and pain. Unlike non-selective NSAIDs, valdecoxib does not inhibit platelet aggregation.</td></tr><tr><th>Absorption</th><td>Oral bioavailability is 83%.</td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>86 L</li>
</ul></td></tr><tr><th>Protein binding</th><td>98%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic (involves CYP3A4 and 2C9)</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Valdecoxib</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET00173">Valdecoxib <i>N</i>-glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/174">Details</a></td></tr><tr><td>Valdecoxib</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01338">Valdecoxib metabolite M2</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1520">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01338">Valdecoxib metabolite M2</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01339">Valdecoxib metabolite M2 glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1521">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01338">Valdecoxib metabolite M2</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01340">Valdecoxib metabolite M7</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1522">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01340">Valdecoxib metabolite M7</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01341">Valdecoxib metabolite M8</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1523">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01338">Valdecoxib metabolite M2</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01342">Valdecoxib metabolite M5</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1524">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01342">Valdecoxib metabolite M5</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01343">Valdecoxib metabolite M5 glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1525">Details</a></td></tr><tr><td>Valdecoxib</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002793" target="_blank">Cytochrome P450 2C9</a></li>
<li><a href="/biodb/bio_entities/BE0002638" target="_blank">Cytochrome P450 3A4</a></li></ul></td><td><a href="/metabolites/DBMET01344">Valdecoxib metabolite M1</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1526">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01344">Valdecoxib metabolite M1</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01345">Valdecoxib metabolite M1 glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1527">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01344">Valdecoxib metabolite M1</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01342">Valdecoxib metabolite M5</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1528">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01344">Valdecoxib metabolite M1</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01346">Valdecoxib metabolite M4</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1529">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01344">Valdecoxib metabolite M1</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01347">Valdecoxib metabolite M3</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1530">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01347">Valdecoxib metabolite M3</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01348">Valdecoxib metabolite M3 glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1531">Details</a></td></tr><tr><td>Valdecoxib</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002793" target="_blank">Cytochrome P450 2C9</a></li>
<li><a href="/biodb/bio_entities/BE0002638" target="_blank">Cytochrome P450 3A4</a></li></ul></td><td><a href="/metabolites/DBMET01349">Valdecoxib metabolite M9</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1532">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01349">Valdecoxib metabolite M9</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002793" target="_blank">Cytochrome P450 2C9</a></li>
<li><a href="/biodb/bio_entities/BE0002638" target="_blank">Cytochrome P450 3A4</a></li></ul></td><td><a href="/metabolites/DBMET01347">Valdecoxib metabolite M3</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1533">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01349">Valdecoxib metabolite M9</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01350">Valdecoxib metabolite M9 glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1534">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td>Valdecoxib is eliminated predominantly via hepatic metabolism with less than 5% of the dose excreted unchanged in the urine and feces. About 70% of the dose is excreted in the urine as metabolites, and about 20% as valdecoxib N-glucuronide.</td></tr><tr><th>Half life</th><td>8-11 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>oral cl=6 L/h</li>
	<li>6 &#8211; 7 L/h [In patients undergoing hemodialysis]</li>
	<li>6 &#8211; 7 L/h [healthy elderly subjects]</li>
</ul></td></tr><tr><th>Toxicity</th><td>Symptoms following acute NSAID overdoses are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Hypertension, acute renal failure, respiratory depression and coma may occur, but are rare.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9386</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.5</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.8864</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8772</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9157</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8576</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7356</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.8918</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.6501</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.5759</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.5385</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8875</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.5958</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8652</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>High CYP Inhibitory Promiscuity</td>
        <td>0.7649</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.8277
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.7399
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9948
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.0680 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9708
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8652
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Gd searle llc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>GD Searle LLC</li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00196">Fluconazole</a></td><td>Fluconazole may increase the effect and toxicity of valdecoxib.</td></tr><tr><td><a href="/drugs/DB01026">Ketoconazole</a></td><td>Ketoconazole may increase the effect and toxicity of valdecoxib.</td></tr><tr><td><a href="/drugs/DB01356">Lithium</a></td><td>The COX-2 inhibitor increases serum levels of lithium</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>